Prestige Brands Holdings, Inc. — Form 10-Q Summary
Reporting period: Three months ended June 30, 2012, the first quarter of fiscal 2013. The filing is by Prestige Brands Holdings, Inc., the company’s name at the time. Dollar amounts below are in millions unless stated otherwise.
Business context and financial results
The company markets and distributes OTC healthcare and household-cleaning products, primarily in the United States and Canada. Results include the recently acquired GSK brands: 15 brands acquired January 31, 2012 and two acquired March 30, 2012. The acquired operations contributed $51.6 million of revenue and $4.4 million of net income in the quarter.
| Metric | Q1 FY2013 | Q1 FY2012 | Change / context |
|---|---|---|---|
| Total revenue | $147.0 | $95.3 | Up 54.3%; mainly GSK acquisition |
| Gross profit / margin | $83.6 / 56.9% | $49.9 / 52.3% | Margin improved, primarily from GSK product mix |
| Operating income / margin | $43.8 / 29.8% | $27.2 / 28.6% | Higher operating income |
| Net income | $14.7 | $14.8 | Slight decrease |
| Diluted EPS | $0.29 | $0.29 | Unchanged as reported |
| Net cash from operations | $14.7 | $15.4 | Down $0.7 |
OTC Healthcare revenue rose 77.2% to $126.2 million; Household Cleaning revenue fell 13.6% to $20.8 million. Cost of sales declined to 43.1% of revenue from 47.7%, while advertising and promotion rose to $20.3 million from $10.2 million. Interest expense increased to $19.9 million from $8.6 million, reflecting substantially higher acquisition-related debt. The prior-year quarter included a $5.1 million pretax litigation-settlement gain; there was no comparable gain this quarter.
Cash flow, debt and liquidity
- Operating cash flow was $14.7 million; investing activities used $1.4 million, including $1.2 million of property and equipment purchases. Financing activities used $27.9 million.
- Cash declined $14.6 million during the quarter, from $19.0 million to $4.4 million. Receivables increased to $69.4 million from $60.2 million; the company cited working-capital needs, including receivables associated with the GSK transition-services arrangement.
- Debt principal was $1.107 billion at June 30, down from $1.135 billion at March 31; debt net of unamortized discount was $1.096 billion. The company repaid $45 million on its term loan and had $17 million outstanding on its $50 million ABL revolver, leaving $33 million of stated borrowing capacity.
- The company reported current assets of $144.4 million and current liabilities of $63.2 million. The term loan interest rate was 5.5% and ABL rate was 2.2% at quarter-end. The company reported compliance with debt covenants.
Management commentary, outlook and risks
Management attributed growth and improved overall gross margin mainly to the GSK acquisition. It identified weaker Comet demand and promotional timing as factors in Household Cleaning’s decline, and higher promotions as a pressure on that segment’s margins. GSK transition services ended June 30; costs were $6.8 million for the period. General and administrative expense also included $0.5 million related to an unsolicited acquisition proposal.
No formal revenue or earnings guidance is provided. Management expected an effective tax rate of 38.9% for the remaining fiscal-year quarters, excluding discrete items, and anticipated covenant compliance in the ensuing year. The filing warns that actual results may differ from forward-looking statements.
- Debt and interest-rate exposure: Variable-rate term and revolver borrowings totaled about $607 million. The filing estimates a one-percentage-point rate increase would adversely affect pretax earnings and cash flows by approximately $4.5 million for the three months ended June 30, 2012.
- Supply and manufacturing: All products are made by third parties. A manufacturer supplying an international brand filed for bankruptcy; supply was insufficient, costs increased, and an alternate supplier had not yet been secured. The current supplier committed to supply through calendar 2012.
- Concentration and operations: Walmart represented 20.6% of gross revenue and 23.3% of accounts receivable at quarter-end. A disruption at the principal distribution center could materially affect distribution and results.
- Brand valuation and market risks: Goodwill and intangible assets totaled about $1.571 billion. No impairment was recorded, but management noted sensitivity to declining sales or margins, competition, consumer preferences, interest rates, and reduced advertising support. Inflation and transport, raw-material and packaging costs may also pressure results.
- Contingencies and reporting: The company described routine legal matters and said their resolution was not expected to have a material adverse effect, taking reserves into account. It revised prior consolidating-statement presentations for intercompany and subsidiary classification errors; it concluded the revisions were not material to consolidated financial statements. Disclosure controls were deemed effective.
Investor verification priorities
- Separate organic performance from acquisition-driven growth, particularly the GSK brands’ ongoing revenue, profitability, and integration costs after transition services ended.
- Monitor Household Cleaning sales, promotional spending, and margins, as well as the supply interruption and alternate-supplier plan for the affected international product.
- Track cash generation, receivables and liquidity against substantial debt service; verify revolver availability and continued covenant compliance.
- Assess exposure to variable interest rates, refinancing and debt restrictions, and confirm the filing’s stated sensitivity assumptions.
- Review future disclosures on GSK purchase-price allocation, brand impairment assumptions, and the previously revised consolidating statements.